IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Neutralization of SARS-CoV-2 pseudovirus by bispecific antibodies a

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern

An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies

A combination of cross-neutralizing antibodies synergizes to prevent SARS- CoV-2 and SARS-CoV pseudovirus infection - ScienceDirect

Viruses, Free Full-Text

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance